MONAMI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.794
EU - Europa 6.384
AS - Asia 4.894
SA - Sud America 890
Continente sconosciuto - Info sul continente non disponibili 167
AF - Africa 138
OC - Oceania 67
Totale 24.334
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.574
RU - Federazione Russa 2.463
IT - Italia 1.491
SG - Singapore 1.332
CN - Cina 1.061
HK - Hong Kong 891
BR - Brasile 718
PL - Polonia 697
VN - Vietnam 582
IE - Irlanda 535
SE - Svezia 366
KR - Corea 363
FR - Francia 222
DE - Germania 188
FI - Finlandia 181
IN - India 164
CA - Canada 130
BD - Bangladesh 112
JO - Giordania 81
GB - Regno Unito 71
AU - Australia 65
AR - Argentina 64
ID - Indonesia 55
MX - Messico 46
IQ - Iraq 44
EC - Ecuador 43
JP - Giappone 43
TR - Turchia 43
UA - Ucraina 43
CH - Svizzera 40
CI - Costa d'Avorio 32
ZA - Sudafrica 31
ES - Italia 24
NL - Olanda 18
MA - Marocco 16
PY - Paraguay 16
CO - Colombia 15
PH - Filippine 14
SA - Arabia Saudita 14
PK - Pakistan 13
VE - Venezuela 12
CL - Cile 11
EG - Egitto 11
NG - Nigeria 11
AZ - Azerbaigian 10
UZ - Uzbekistan 10
DZ - Algeria 9
LT - Lituania 9
KZ - Kazakistan 8
AE - Emirati Arabi Uniti 6
BE - Belgio 6
DO - Repubblica Dominicana 6
HN - Honduras 6
IR - Iran 6
KE - Kenya 6
NP - Nepal 6
TN - Tunisia 6
AL - Albania 5
BJ - Benin 5
JM - Giamaica 5
PE - Perù 5
UY - Uruguay 5
BB - Barbados 4
BH - Bahrain 4
CR - Costa Rica 4
GT - Guatemala 4
IL - Israele 4
MY - Malesia 4
NI - Nicaragua 4
DK - Danimarca 3
LV - Lettonia 3
PS - Palestinian Territory 3
PT - Portogallo 3
SC - Seychelles 3
SV - El Salvador 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
BG - Bulgaria 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
SI - Slovenia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BO - Bolivia 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
Totale 24.153
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.447
Ashburn 1.439
Fairfield 1.096
Singapore 972
Hong Kong 772
Warsaw 693
Dublin 533
Chandler 526
Woodbridge 496
Seattle 486
Cambridge 413
Houston 382
Seoul 356
Milan 350
Wilmington 342
San Jose 315
Beijing 299
Lawrence 225
Altamura 224
Ho Chi Minh City 205
Ann Arbor 192
Moscow 184
Los Angeles 175
Princeton 169
Buffalo 141
Hanoi 140
The Dalles 140
Lauterbourg 134
Rome 122
Mumbai 113
Hefei 110
Boston 101
New York 96
Munich 84
San Diego 80
Boardman 79
Florence 77
Medford 72
Dallas 71
Helsinki 68
Shanghai 62
São Paulo 61
Council Bluffs 58
Melbourne 56
Clifton 47
Paris 47
Kent 44
Naples 39
Toronto 38
Turin 37
Bern 34
Jacksonville 34
Tokyo 34
Abidjan 32
Turku 32
Bologna 30
Falls Church 29
Redondo Beach 28
Rio de Janeiro 28
Figino 27
Izmir 27
Jakarta 27
Phoenix 25
Orem 24
Guangzhou 23
Hillsboro 23
London 23
Andover 22
Frankfurt am Main 20
Baghdad 18
Brooklyn 18
Da Nang 18
Montreal 18
Tianjin 18
Chicago 17
Norwalk 17
Curitiba 16
Mexico City 16
Miano 16
Quito 16
Bari 15
Biên Hòa 15
Falkenstein 14
Lappeenranta 14
Palermo 14
Belo Horizonte 13
Guayaquil 13
Johannesburg 13
Padua 13
Atlanta 12
Catania 12
Dong Ket 12
Haiphong 12
Porto Alegre 12
Thái Nguyên 12
Amman 11
Bengaluru 11
Brasília 11
Redmond 11
Redwood City 11
Totale 16.369
Salva come PNG Salva come JPEG
Nome #
Resistin level in coronary artery disease and heart failure: the central role of kidney function 331
Glucagon-Like Peptide-1, Diabetes, and Cognitive Decline: Possible Pathophysiological Links and Therapeutic Opportunities 330
Left ventricular cavity obliteration during dobutamine stress echocardiography in diabetic patients 329
Sulphonylureas and cancer: a case-control study. 287
Alternative treatment or alternative to treatment? A systematic review of randomized trials on homeopathic preparations for diabetes and obesity 248
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis. 247
Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study. 246
Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events: A comprehensive meta-analysis of randomized controlled trials 220
A randomized, open-label, controlled trial to evaluate the antimicrobial and surgical effect of CO2 laser treatment in diabetic infected foot ulcers: DULCIS (diabetic ulcer, CO2 laser, and infections) study 219
Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction 215
Are psychopathological features relevant predictors of glucose control in patients with type 2 diabetes? A prospective study 215
Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies 211
DPP-4 inhibitors and lipids: Systematic review and meta-analysis 206
Adherence to and early adverse events of COVID-19 vaccine in a cohort of 600 Italian breastfeeding and pregnant physicians 204
Amphetamine derivatives and obesity 201
Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study 200
Age and comorbidity in acute myocardial infarction: a report from the AMI-Florence Italian registry 194
Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism. 191
Targeting educational therapy for type 2 diabetes: Identification of predictors of therapeutic success 190
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials 190
Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: Meta-analysis of placebo-controlled trials 187
Impact of influenza vaccination on all-cause mortality and hospitalization for pneumonia in adults and the elderly with diabetes: A meta-analysis of observational studies 187
Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily 187
Alpha-Tocopherol and contrast-induced nephropathy: a meta-analysis of randomized controlled trials 185
Fasting and post-prandial glucose and diabetic complication. A meta-analysis 182
Effect of insulin secretagogues on major cardiovascular events and all-cause mortality: A meta-analysis of randomized controlled trials 180
Is obesity a further cardiovascular risk factor in patients with erectile dysfunction? 179
HbA1c levels and all-cause mortality in type 2 diabetic patients: Epidemiological evidence of the need for personalised therapeutic targets 179
Effects of SGLT-2 inhibitors on diabetic ketoacidosis: A meta-analysis of randomised controlled trials 179
Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. 177
CO2 laser for the treatment of diabetic foot ulcers with exposed bone. A consecutive series of type 2 diabetic patients 176
Factors associated with increased all-cause mortality during the COVID-19 pandemic in Italy 176
Priapus is Happier with Venus than with Bacchus 175
Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. 174
Low Testosterone is Associated with an Increased Risk of MACE Lethality in Subjects with Erectile Dysfunction 174
Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials 173
Type 1 diabetes and periodontitis: prevalence and periodontal destruction—a systematic review 173
Efficacy and safety of different basal and prandial insulin analogues for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials 173
Antimicrobial photodynamic therapy in infected diabetic foot ulcers: A multicenter preliminary experience 172
Toe amputations with SGLT-2 inhibitors: data from randomized clinical trials 171
Development of the Italian Clinical Practice Guidelines on Bariatric and Metabolic Surgery: Design and Methodological Aspects 170
Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes 170
Immune checkpoints inhibitors and hyperglycemia: A Meta-analysis of randomized controlled trials 170
2023 update on Italian guidelines for the treatment of type 2 diabetes 168
Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: A systematic review and meta-analysis of randomized controlled trials 167
Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials 167
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials 167
Failure to metformin and insulin secretagogue monotherapy: an observational cohort study. 166
Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients. 166
Post-prandial glucose and diabetic complications: Systematic review of observational studies 166
Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials 166
All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides. 164
All-cause and cardiovascular mortality in a consecutive series of patients with diabetic foot osteomyelitis 164
Metabolic surgery for the treatment of type 2 diabetes: A network meta-analysis of randomized controlled trials 163
Dipeptidyl peptidase-4 inhibitors and bone fractures: A meta-analysis of randomized clinical trials 162
Retrospective Matched Case-Control Study on the Use of CO2 Laser for the Treatment of Nonhealing Diabetic Foot Ulcers: The DULCIS-2 (Diabetic ULcer, CO2 Laser, and Infections) Study 161
Glomerular hyperfiltration and metabolic syndrome: results from the FIrenze-BAgno A Ripoli (FIBAR) Study 161
Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials 160
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: A meta-analysis of randomized clinical trials 159
Deprescription in elderly patients with type 2 diabetes mellitus 159
Bone Fractures with Sodium-Glucose Co-transporter-2 Inhibitors: How Real is the Risk? 159
Cardiovascular Safety of Incretin-Based Therapies in Type 2 Diabetes: Systematic Review of Integrated Analyses and Randomized Controlled Trials 158
Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study. 157
Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trials 156
Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials 156
combined continuous glucose monitoring and subcutaneous insulin infusion versus self‐monitoring of blood glucose with optimized multiple injections in type 1 diabetes: A randomized cross‐over trial 155
Association between different screening strategies for SARS-CoV-2 and deaths and severe disease in Italy 155
Dypeptidylpeptidase-4 inhibitors and the cardiovascular system: How to manage the fil rouge 155
Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials 155
Reply to Gaertner, K. and Frass, M 152
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trials 152
Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials 152
Peripheral artery disease and amputations with Sodium-Glucose co-Transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials 151
Potential Impact of Climate on Novel Corona Virus (COVID-19) Epidemic 151
Bypass surgery versus endovascular revascularization for occlusive infrainguinal peripheral artery disease: a meta-analysis of randomized controlled trials for the development of the Italian Guidelines for the treatment of diabetic foot syndrome 149
Bariatric Surgery for Patients with Overweight/Obesity. A Comprehensive Grading Methodology and Network Metanalysis of Randomized Controlled Trials on Weight Loss Outcomes and Adverse Events 149
Coronary artery disease screening in type II diabetic patients: Prognostic value of rest and stress echocardiography 149
Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials 148
Severe Depressive Symptoms and Cardiovascular Risk in Subjects with Erectile Dysfunction 147
Safety of dipeptidyl peptidase-4 inhibitors: A meta-analysis of randomized clinical trials 147
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials 147
Low diastolic ambulatory blood pressure is associated with greater all-cause mortality in older patients with hypertension 147
All-cause mortality and cardiovascular events in patients with type 2 diabetes treated with alpha-glucosidase inhibitors: A meta-analysis of randomized controlled trials 147
Efficacy and effects of bariatric surgery in the treatment of obesity: Network meta-analysis of randomized controlled trials 147
Effectiveness of pneumococcal vaccination on hospitalization and death in the adult and older adult diabetic population: a systematic review 146
Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials 146
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials. 146
Doses of insulin and its analogues and cancer occurence in insulin-treated type 2 diabetic patients. 144
Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients. 144
Hypertension and metabolic syndrome in the elderly 144
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS) 143
[Psychological disorders and cardiovascular diseases] 142
Efficacy and safety of glucose-lowering agents in patients with type 2 diabetes: A network meta-analysis of randomized, active comparator-controlled trials 142
Low-carbohydrate diets and type 2 diabetes treatment: a meta-analysis of randomized controlled trials 141
Major Amputation In Non-Healing Ulcers: Outcomes and Economic Issues. Data from a Cohort of Patients with Diabetic Foot Ulcers 141
Cholelithiasis in patientes treated with Glucagon-Like Peptide-1 Receptor: An updated meta-analysis of randomized controlled trials 140
Rosiglitazone and cardiovascular risk. 140
Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials 140
Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials 138
Italian guidelines for the treatment of type 2 diabetes 138
Totale 17.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.683
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022955 0 62 106 59 33 53 37 73 46 52 137 297
2022/20232.541 300 615 119 183 129 406 292 92 251 20 81 53
2023/2024880 42 92 152 47 54 76 44 172 22 85 62 32
2024/20256.929 219 733 449 1.042 2.042 885 101 484 347 173 224 230
2025/20267.941 759 990 572 711 966 288 850 447 473 435 256 1.194
2026/2027446 398 48 0 0 0 0 0 0 0 0 0 0
Totale 24.334